Maik Schuler
Pfizer (United States)(US)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, DNA Repair Mechanisms, Effects and risks of endocrine disrupting chemicals, Genetically Modified Organisms Research, Molecular Biology Techniques and Applications
Most-Cited Works
- → Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing(2006)131 cited
- → Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells(1995)118 cited
- → Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing(2010)105 cited
- → Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide(2014)93 cited
- → A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro(1997)89 cited
- → Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay(2017)73 cited
- → Induction of micronuclei, hyperdiploidy and chromosomal breakage affecting the centric/pericentric regions of chromosomes 1 and 9 in human amniotic fluid cells after treatment with asbestos and ceramic fibers(1997)63 cited
- → Follow‐up actions from positive results of in vitro genetic toxicity testing(2010)60 cited
- → Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus)(2011)56 cited
- → Application of the adverse outcome pathway framework to genotoxic modes of action(2019)55 cited